Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human

A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Grynkiewicz, G., Poenie, M., & Tsien, R. Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83641-4 · Cited by 21,722 · see citing works

Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023 · see citing works

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study

Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699 · see citing works

Cardiac excitation–contraction coupling

Bers, D., & Despa, S. (2002) · Nature · doi:10.1038/415198a · Cited by 4,927 · see citing works

A simplified system for generating recombinant adenoviruses

He, T., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,209 · see citing works

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure

Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125 · see citing works

The epidemiology of heart failure: The Framingham Study

Ho, K. K. L., Pinsky, J. L., Kannel, W. B., & Levy, D. A. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90455-a · Cited by 2,230 · see citing works

Calcium release from the sarcoplasmic reticulum

Endo, M. (1977) · Physiological Reviews · doi:10.1152/physrev.1977.57.1.71 · Cited by 1,591 · see citing works

Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.

Luo, W., Grupp, I. L., Harrer, J. M., Ponniah, S., Grupp, G., Duffy, J. J., Doetschman, T., & Kranias, E. G. (1994) · Circulation Research · doi:10.1161/01.res.75.3.401 · Cited by 706 · see citing works

Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure.

JBeuckelmann, D., MNäbauer, & EErdmann (1992) · Circulation · Cited by 662 · see citing works

Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure.

Beuckelmann, D. J., Näbauer, M., & Erdmann, E. (1992) · Circulation · doi:10.1161/01.cir.85.3.1046 · Cited by 636 · see citing works

A Mouse Model of Familial Hypertrophic Cardiomyopathy

Geisterfer-Lowrance, A. A. T., Christe, M. E., Conner, D. A., Ingwall, J. S., Schöen, F. J., Seidman, C. E., & Seidman, J. G. (1996) · Science · doi:10.1126/science.272.5262.731 · Cited by 554 · see citing works

Alterations of Sarcoplasmic Reticulum Proteins in Failing Human Dilated Cardiomyopathy

Meyer, M., Schillinger, W., Pieske, B., Holubarsch, C., Heilmann, C., Posival, H., Kuwajima, G., Mikoshiba, K., Just, H., & Hasenfuss, G. (1995) · Circulation · doi:10.1161/01.cir.92.4.778 · Cited by 535 · see citing works

Synergistic Polymorphisms of β1- and α2C-Adrenergic Receptors and the Risk of Congestive Heart Failure

Small, K. M., Wagoner, L. E., Levin, A. M., Kardia, S. L. R., & Liggett, S. B. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020803 · Cited by 524 · see citing works

Alterations of calcium-regulatory proteins in heart failure

Hasenfuss, G. P. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00277-0 · Cited by 439 · see citing works

Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.

WLuo, LGrupp, I., JHarrer, SPonniah, GGrupp, JDuffy, J., TDoetschman, & GKranias, E. (1994) · Circulation Research · Cited by 403 · see citing works

Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery

Hoshijima, M., Ikeda, Y., Iwanaga, Y., Minamisawa, S., Date, M., Gu, Y., Iwatate, M., Li, M., Wang, L., Wilson, J. M., et al. (2002) · Nature Medicine · doi:10.1038/nm739 · Cited by 372 · see citing works

Phospholamban Inhibitory Function Is Activated by Depolymerization

Kimura, Y., Kurzydlowski, K., Tada, M., & MacLennan, D. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15061 · Cited by 283 · see citing works

Characterization of a transient outward K+ current with inward rectification in canine ventricular myocytes

Li, G., Sun, H., & Nattel, S. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.3.c577 · Cited by 263 · see citing works

A Leucine Zipper Stabilizes the Pentameric Membrane Domain of Phospholamban and Forms a Coiled-coil Pore Structure

Simmerman, H. K. B., Kobayashi, Y. M., Autry, J. M., & Jones, L. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5941 · Cited by 257 · see citing works

In Vivo Echocardiographic Detection of Enhanced Left Ventricular Function in Gene-Targeted Mice With Phospholamban Deficiency

Hoit, B. D., Khoury, S. F., Kranias, E. G., Ball, N. A., & Walsh, R. A. (1995) · Circulation Research · doi:10.1161/01.res.77.3.632 · Cited by 238 · see citing works

Cardiomyocytes of Noncardiac Origin in Myocardial Biopsies of Human Transplanted Hearts

Müller, P., Pfeiffer, P. C., Koglin, J., et al. (2002) · Circulation · doi:10.1161/01.cir.0000022405.68464.ca · Cited by 222 · see citing works

Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects

Li, L., Chu, G., Kranias, E. G., & Bers, D. M. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.4.h1335 · Cited by 222 · see citing works

Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction

White, D. C., Hata, J. A., Shah, A. S., Glower, D. D., Lefkowitz, R. J., & Koch, W. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090091197 · Cited by 207 · see citing works

Structural organization of the pentameric transmembrane alpha‐helices of phospholamban, a cardiac ion channel.

Arkin, I. T., Adams, P. D., MacKenzie, K. R., et al. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06801.x · Cited by 185 · see citing works

Cardiomyopathies: from genetics to the prospect of treatment

Franz, W.-M., Müller, O. J., & Katus, H. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06657-0 · Cited by 177 · see citing works

Murine Cardiac Function

Kass, D. A., Hare, J. M., & Georgakopoulos, D. (1998) · Circulation Research · doi:10.1161/01.res.82.4.519 · Cited by 177 · see citing works

Gender Influences on Sarcoplasmic Reticulum Ca2+-handling in Failing Human Myocardium

Dash, R., Frank, K. F., Carr, A. N., Moravec, C. S., & Kranias, E. G. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1394 · Cited by 171 · see citing works

Phospholamban and Cardiac Contractile Function

Brittsan, A. G., & Kranias, E. G. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1270 · Cited by 170 · see citing works

Superinhibition of Sarcoplasmic Reticulum Function by Phospholamban Induces Cardiac Contractile Failure

Haghighi, K., Schmidt, A. G., Hoit, B. D., Brittsan, A. G., Yatani, A., Lester, J. W., Zhai, J., Kimura, Y., Dorn, G. W., MacLennan, D. H., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102403200 · Cited by 127 · see citing works

Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy

Song, Q., Schmidt, A. G., Hahn, H. S., Carr, A. N., Frank, B., Pater, L. E., Gerst, M., Young, K. B., Hoit, B. D., McConnell, B. K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316738 · Cited by 122 · see citing works

Sarcoplasmic reticulum Ca2+ uptake and thapsigargin sensitivity in permeabilized rabbit and rat ventricular myocytes.

Hove‐Madsen, L., & Bers, D. M. (1993) · Circulation Research · doi:10.1161/01.res.73.5.820 · Cited by 120 · see citing works

Transmembrane Helix M6 in Sarco(endo)plasmic Reticulum Ca2+-ATPase Forms a Functional Interaction Site with Phospholamban

Asahi, M., Kimura, Y., Kurzydlowski, K., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32855 · Cited by 105 · see citing works

Maximal Inhibition of SERCA2 Ca2+ Affinity by Phospholamban in Transgenic Hearts Overexpressing a Non-phosphorylatable Form of Phospholamban

Brittsan, A. G., Carr, A. N., Schmidt, A. G., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12129 · Cited by 92 · see citing works

Ablation of PLB exacerbates ischemic injury to a lesser extent in female than male mice: protective role of NO

Cross, H. R., Kranias, E. G., Murphy, E., & Steenbergen, C. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00567.2002 · Cited by 77 · see citing works

Synergistic polymorphisms of the β1- and α2c-adrenergic receptors and the risk of congestive heart failure

Small, K. M., Wagoner, L. E., Levin, S. M., et al. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00063-1 · Cited by 73 · see citing works

The enhanced contractility of the phospholamban-deficient mouse heart persists with aging

Slack, J. P., Grupp, I. L., Dash, R., Holder, D., Schmidt, A., Gerst, M. J., Tamura, T., Tilgmann, C., James, P. F., Johnson, R., et al. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1370 · Cited by 64 · see citing works

Inotropes and β-blockers: Is there a need for new guidelines?

Bristow, M. R., Shakar, S. F., Linseman, J. V., & Lowes, B. D. (2001) · Journal of Cardiac Failure · doi:10.1054/jcaf.2001.26655 · Cited by 61 · see citing works

Overexpression of Na+/Ca2+exchanger alters contractility and SR Ca2+content in adult rat myocytes

Zhang, X.-Q., Song, J., Rothblum, L. I., et al. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.5.h2079 · Cited by 51 · see citing works

Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure

SCHMIDT, A., ZHAI, J., CARR, A., et al. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00541-2 · Cited by 44 · see citing works

Phospholamban deficiency does not compromise exercise capacity

Desai, K. H., Schauble, E. H., Luo, W., et al. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.4.h1172 · Cited by 41 · see citing works

The Human Phospholamban Gene: Structure and Expression

McTiernan, C. F., Frye, C. S., Lemster, B. H., et al. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0904 · Cited by 38 · see citing works

Transgenic Rabbits Expressing Mutant Essential Light Chain do not Develop Hypertrophic Cardiomyopathy

James, J. F., Zhang, Y., Wright, K., Witt, S., Glascock, E., Osińska, H. E., Klevitsky, R., Martin, L. J., Yager, K. L., Sanbe, A., et al. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2025 · Cited by 25 · see citing works

Current Concepts in the Treatment of Congestive Heart Failure

Cohn, J. N. (2008) · Cardiology · doi:10.1159/000177477 · Cited by 15 · see citing works

Phospholamban: a crucial regulator of cardiac contractility

MacLennan, D. H., & Kranias, E. G. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1151 · Cited by 1,088 · see citing works

Small and large animal models in cardiac contraction research: advantages and disadvantages

Milani-Nejad, N., & Janssen, P. M. L. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.007 · Cited by 484 · see citing works

Ca²⁺–calmodulin‐dependent protein kinase expression and signalling in skeletal muscle during exercise

Rose, A. J., Kiens, B., & Richter, E. A. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.111757 · Cited by 247 · see citing works

Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model

Pleger, S. T., Shan, C., Ksienzyk, J., Bekeredjian, R., Boekstegers, P., Hinkel, R., Schinkel, S., Leuchs, B., Ludwig, J., Qiu, G., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002097 · Cited by 234 · see citing works

Altered Myocardial Calcium Cycling and Energetics in Heart Failure—A Rational Approach for Disease Treatment

Gorski, P. A., Ceholski, D. K., & Hajjar, R. J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.005 · Cited by 213 · see citing works

Variant Interpretation for Dilated Cardiomyopathy: Refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study

Morales, A., Kinnamon, D. D., Jordan, E., Platt, J., Vatta, M., Dorschner, M. O., Starkey, C. A., Mead, J. O., Ai, T., Burke, W., et al. (2020) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.119.002480 · Cited by 114 · see citing works

Human induced pluripotent stem cells as a platform for personalized and precision cardiovascular medicine

Matsa, E., Ahrens, J. H., & Wu, J. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00036.2015 · Cited by 105 · see citing works

A novel human T17N-phospholamban variation in idiopathic dilated cardiomyopathy

Mollanoori, H., Naderi, N., Amin, A., et al. (2018) · Gene Reports · doi:10.1016/j.genrep.2018.06.014 · Cited by 7 · see citing works

Study of dilated cardiomyopathy and phospholamban

Zheng, X.-M. (2011) · International journal of pediatrics · doi:10.3760/cma.j.issn.1673-4408.2011.01.019

CRISPR/Cas9-Mediated Insertion of loxP Sites in the Mouse Dock7 Gene Provides an Effective Alternative to Use of Targeted Embryonic Stem Cells

Bishop, K. A., Harrington, A. N., Kouranova, E. V., Weinstein, E. J., Rosen, C. J., Cui, X., & Liaw, L. (2016) · G3 Genes Genomes Genetics · doi:10.1534/g3.116.030601 · Cited by 33 · see citing works

Null and conditionalsemaphorin 3B alleles using a flexiblepuro?tk loxP/FRT vector

van der Weyden, L., Adams, D. J., Harris, L. W., Tannahill, D., Arends, M. J., & Bradley, A. (2005) · genesis · doi:10.1002/gene.20111 · Cited by 40 · see citing works

Conditional Gene Knockout Using Cre Recombinase

Le, Y.-Z., & Sauer, B. (2003) · Humana Press eBooks · doi:10.1385/1-59259-065-9:477 · Cited by 88 · see citing works